Treatment of patients with Crohn's disease to delay the natural evolution of the disease and avoid the development of complicated disease as well as the need for hospitalization and surgery is desirable. Gert Van Assche and colleagues discuss the disease-modifying potential of immunosuppressive and anti-tumor necrosis factor therapies, especially when given as early, aggressive therapy.
- G. Van Assche
- Séverine Vermeire
- Paul Rutgeerts
